Salud financiera de hoja de balance de Insulet
Salud financiera controles de criterios 4/6
Insulet tiene un patrimonio de accionistas total de $732.7M y una deuda total de $1.4B, lo que sitúa su ratio deuda-patrimonio en 193.2%. Sus activos y pasivos totales son $2.6B y $1.9B respectivamente. El BAIT de Insulet es de $235.8M, por lo que su ratio de cobertura de intereses es de 31. Tiene efectivo e inversiones a corto plazo que ascienden a $704.2M.
Información clave
177.2%
Ratio deuda-patrimonio
US$1.40b
Deuda
| Ratio de cobertura de intereses | 44.2x |
| Efectivo | US$751.20m |
| Patrimonio | US$790.70m |
| Total pasivo | US$1.83b |
| Activos totales | US$2.62b |
Actualizaciones recientes sobre salud financiera
Is Insulet (NASDAQ:PODD) A Risky Investment?
Apr 29
Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jan 09We Think Insulet (NASDAQ:PODD) Is Taking Some Risk With Its Debt
Oct 01Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jun 18Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt Burden
Jan 24Insulet (NASDAQ:PODD) Has A Pretty Healthy Balance Sheet
Oct 02Recent updates
We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)
May 26At US$166, Is It Time To Put Insulet Corporation (NASDAQ:PODD) On Your Watch List?
May 12Is Insulet (NASDAQ:PODD) A Risky Investment?
Apr 29Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Apr 14Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)
Mar 31Insulet: Insulating Patients, Investors Still Have To Wait
Mar 28Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price
Feb 19Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?
Jan 22Insulet: An Interesting, Yet Expensive, Story
Jan 10Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jan 09Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Dec 27Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Nov 14Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue
Oct 31We Think Insulet (NASDAQ:PODD) Is Taking Some Risk With Its Debt
Oct 01Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?
Sep 16Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Aug 14Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Jul 31Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jun 18Getting In Cheap On Insulet Corporation (NASDAQ:PODD) Might Be Difficult
May 22Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Apr 30Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt Burden
Jan 24Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue
Dec 28Insulet: An Overpriced Play In The Medical Space
Oct 18Insulet (NASDAQ:PODD) Has A Pretty Healthy Balance Sheet
Oct 02Insulet automated insulin delivery system Omnipod 5 gets CE mark
Sep 20The Return Trends At Insulet (NASDAQ:PODD) Look Promising
Sep 05Insulet wins FDA nod to use insulin delivery system in 2 – 5-year-olds
Aug 22Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($1.6B) de PODD superan a sus pasivos a corto plazo ($451.2M).
Pasivo a largo plazo: Los activos a corto plazo de PODD ($1.6B) superan a sus pasivos a largo plazo ($1.4B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de PODD (97.1%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de PODD ha pasado de 279.1% a 193.2% en los últimos 5 años.
Cobertura de la deuda: La deuda de PODD no está bien cubierta por el flujo de caja operativo (10.3%).
Cobertura de intereses: Los pagos de intereses de la deuda de PODD están bien cubiertos por el BAIT (31x cobertura).